Composition for stimulating insulin secretion from cells and use thereof
US-2018280456-A1 · Oct 4, 2018 · US
US10653732B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10653732-B2 |
| Application number | US-201815935634-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 26, 2018 |
| Priority date | Mar 27, 2017 |
| Publication date | May 19, 2020 |
| Grant date | May 19, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are a composition for stimulating insulin secretion from cells, the composition including a Hypoxylon truncatum extract or an active ingredient thereof, and a method of stimulating insulin secretion from cells.
Opening claim text (preview).
What is claimed is: 1. A method of stimulating insulin secretion from cells, the method comprising contacting a composition or an extract with cells, wherein the composition comprises any stereoisomer selected from the group consisting of Formulae I, II, and III, a solvate or hydrate thereof, or a mixture thereof, or a physiologically acceptable salt thereof: wherein, in Formula I, II, and III, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12 are each independently H or (C 1 -C 6 )-alkyl, and the extract is a Hypoxylon sp. mushroom extract comprising any stereoisomer selected from the group consisting of Formulae I, II, and III, a solvate or hydrate thereof, or a mixture thereof, or a physiologically acceptable salt thereof: wherein, in Formula I, II, and III, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12 are each independently H or (C 1 - C 6 ) alkyl. 2. The method of claim 1 , wherein the contacting is to administer the composition or the extract to a subject. 3. The method of claim 1 , wherein the cells are pancreatic beta cells. 4. The method of claim 1 , wherein the method is to prevent or treat diabetes in the subject. 5. The method of claim 1 , wherein R 1 and R 5 are each independently H or (C 1 -C 6 )-alkyl, and R 2 , R 3 , R 4 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12 are each independently H. 6. The method of claim 5 , wherein R 1 and R 5 are each independently H, methyl, or ethyl. 7. The method of claim 1 , wherein the compounds of Formula I, II, and III exist at a weight ratio of 1.0: 0.20 to 0.60: 0.50 to 1.00 in the composition. 8. The method of claim 1 , the composition further comprising an excipient or a carrier which is acceptable for use in pharmaceuticals or foods. 9. The method of claim 5 , wherein the composition is a pharmaceutical composition or a food composition. 10. The method of claim 4 , wherein the diabetes is type 1 or type 2 diabetes. 11. The method of claim 1 , the composition comprising a Hypoxylon sp. mushroom extract comprising any stereoisomer selected from the group consisting of Formulae I, II, and III, or a mixture thereof, or a physiologically acceptable salt thereof. 12. The method of claim 11 , wherein the extract is extracted by an extraction method comprising contacting Hypoxylon sp. mushroom with water, (C 1 -C 3 )-alcohol, or a mixture thereof. 13. The method of claim 12 , wherein the extract is obtained by fractionating the extract with a R 13 —COO—R 14 solvent, wherein R 13 and R 14 are each independently (C 1 -C 6 )-alkyl. 14. The method of claim 12 , wherein the extract is a fraction obtained by fractionating the extract with a (C 4 -C 12 )-alkane solvent to obtain a fraction, removing this fraction to obtain a residue, fractionating the residue with a R 13 —COO—R 14 solvent, wherein R 13 and R 14 is each independently (C 1 -C 6 )-alkyl, thereby obtained the fraction.
Ascomycota · CPC title
using additives (addition of substantially indigestible substances A23L33/21) · CPC title
for hyperglycaemia, e.g. antidiabetics · CPC title
Complex extraction schemes, e.g. fractionation or repeated extraction steps · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.